Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Oxford Biotrans
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Oxford-Biotrans.jpg)
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Oxford-Biotrans.jpg)
Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.
Incorporated in September 2013
Origin: Oxford University, Department of Chemistry
Perspectum Diagnostics
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Perspectum.jpg)
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Perspectum.jpg)
Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.
Incorporated in April 2013
Origin: Oxford University, Radcliffe Department of Medicine
2012
Run3D
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Run3D.jpg)
![](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Run3D.jpg)
Offering the most accurate assessment of running biomechanics that modern science is able to provide.
Incorporated in December 2012
Origin: Oxford University, Department of Engineering Science
Oxford VacMedix
![Oxford Vacmedix logo](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Oxford-Vacmedix-logo.jpg)
![Oxford Vacmedix logo](https://innovation.ox.ac.uk/wp-content/uploads/2015/11/Oxford-Vacmedix-logo.jpg)
Cellular immunity vaccines.
Incorporated in September 2012
Origin: Oxford University, Weatherall Institute of Molecular Medicine
Oxehealth
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxehealth-Logo-1.png)
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxehealth-Logo-1.png)
Revolutionary healthcare technology that measures medical vital signs without physical contact.
Incorporated in August 2012
Origin: Oxford University, Institute of Biomedical Engineering
Intelligent Ultrasound (Medaphor)
![Intelligent Ultrasound logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Intelligent-Ultrasound-logo.jpg)
![Intelligent Ultrasound logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Intelligent-Ultrasound-logo.jpg)
Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.
Incorporated in July 2012
Origin: Oxford University, Institute of Biomedical Engineering
2011
Oxford Cancer Biomarkers
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxford-Cancer-Biomarkers-logo.png)
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxford-Cancer-Biomarkers-logo.png)
Pioneering biomarker technologies for cancer therapies.
Incorporated in December 2011
Origin: Oxford University, Radcliffe Department of Oncology
Oxford Imaging Detectors
![Oxford Imaging Detectors ltd logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxford-Imaging-Detectors-logo.jpg)
Oxford Multi Spectral
Oxtex
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxtex-logo.png)
First Light Fusion (Oxyntix)
![](https://innovation.ox.ac.uk/wp-content/uploads/2018/04/First-Light-logo.jpg)
![](https://innovation.ox.ac.uk/wp-content/uploads/2018/04/First-Light-logo.jpg)
Energy from Fusion.
Incorporated in July 2011
Origin: Oxford University, Department of Engineering Science
Cella Energy
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Cella-logo.png)
2010
Oxford PV
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxford-Photovoltaics-logo.png)
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxford-Photovoltaics-logo.png)
Oxford PV are developing new photovoltaic cells that will provide a sustainable solar energy source.
Incorporated in November 2010
Origin: Oxford University, Department of Physics
IXO Therapeutics
Tidal – Kepler Energy
![Kepler Energy logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Kepler-Energy.jpg)
![Kepler Energy logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Kepler-Energy.jpg)
Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.
Incorporated in October 2010
Origin: Oxford University, Department of Engineering Science
Oxems
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxems-logo.png)
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Oxems-logo.png)
Oxford Electromagnetic Solutions - smart asset management through underground network visibility.
Incorporated in June 2010
Origin: Oxford University, Department of Engineering Science
Oxepi
2009
Yasa Motors
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Yasa_Lockup_RGB.png)
![](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/Yasa_Lockup_RGB.png)
YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.
Incorporated in August 2009
Origin: Oxford University, Department of Engineering Science
CN Bio Innovations
![CN Bio logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/CN-Bio-logo.jpg)
![CN Bio logo](https://innovation.ox.ac.uk/wp-content/uploads/2016/02/CN-Bio-logo.jpg)
Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.
Incorporated in July 2009
Origin: Oxford University, Institute of Biomedical Engineering